The extraction of heroin, caffeine, diphenyl hydantoin, and phenobarbital has been measured in the newborn, suckling, and adult brain. Anticonvulsant drugs such as diphenylhydantoin and phenobarbital are bound by plasma protein, and it is generally believed that only the fraction of drug that is free (dialyzable) in vitro is available for transport through the blood-brain barrier in vivo. In both the adult and neonatal rat or rabbit, lipid mediated transport of free phenytoin occurs. In addition, a fraction of the drug that enters the capillary bound to plasma protein also gains access to the brain. A greater amount of protein-bound drug permeates the newborn brain, and this is ascribed to a longer capillary transit time in the neonate. With regard to phenobarbital, the total
(i.e., both free and protein-bound) plasma drug enters the newborn brain. In contrast, no protein-bound phenobar bital permeates the adult brain, and it is only the free drug fraction that gains access to the brain. Since the blood-brain barrier permeability-surface area product for the two anticonvulsants is unchanged in newborn and older animals, the age-related differences in brain uptake of protein-bound drugs can be attributed to develop mental changes in cerebral blood flow and capillary transit time. The increased transport of protein-bound drugs in the newborn may cause increased concentrations (i.e., brain:plasma ratios) of these anticonvulsants in the neo natal brain. Key Words: Brain permeability-Caffeine Heroin-Phenobarbital-Phenytoin.
adverse effects of seizures in developing infants, early detection and effective treatment with anti convulsant drugs are advocated (Painter et al., 1978 (Painter et al., , 1981 . Another unusual feature of phenobarbital and phenytoin therapy is that doses administered to ne onates for seizure control may be 5-10 times greater than the doses administered to adults (Dodson et aI., 1976) . Presumably this is because the drug half life has some inverse relationship to age (Neims et aI., 1976; Loughnan et aI., 1977; Painter et aI., 1978 Painter et aI., , 1981 . Half-lives of 50-60 (Mirkin, 1971 ) to 194 ± 17 h (Painter et aI., 1981) for phenytoin in neonates greatly exceed the mean 30-h half-life reported in adults (Glazko and Chang, 1972) , and metabolic clearance and half-life change quite rapidly in the neonate (Neims et aI., 1976) .
Clinical studies indicate that the brain:plasma ra tios of certain anticonvulsants may vary with ges tational age (Painter et aI., 1981) . Although perme ability differences between adult and neonatal brain capillaries have not been described for anticonvul-sants, developmental differences in brain capillary transport are known to occur for other compounds (Cornford et aI., 1982a) . Since the blood-brain bar rier (BBB) is functional at birth (Saunders, 1977) , and certain restrictive properties of brain endothelia are apparent in both rats (Olsson et aI., 1968 ) and sheep (Evans et aI., 1974) sometime before the end of the second trimester of fetal life, a study of the possible age-related changes in delivery of these drugs to the brain was initiated. In the present work, we measured brain extraction of [14C]phenytoin and [14C]phenobarbital in newborn and adult rats after intracarotid or intra cardiac injection of isotopes in anesthetized ani mals, and described age-related differences in brain uptake and their relationship to cerebral blood flow rates. Comparative studies measuring brain uptakes of caffeine and heroin contrasted in that no signif icant age-related changes were observed.
METHODS

Animals
New Zealand white rabbits were obtained from a com mercial supplier; adults were maintained on a standard diet of water and rabbit chow. All animal studies were performed in the early afternoon. Although newborn rab bits were obtained as soon as possible postpartum, in most instances they were a minimum of 10 h old and routinely had maternal milk in the stomach. The common carotid artery was surgically exposed under ether anes thesia and cannulated with a 30-gauge (0.3 mm) needle. The intracarotid injection technique ) was modified slightly for study of newborn and adult rabbits. Approximately 0.1-0.2 ml of 14C anticonvulsant (0.1 /-LCi) , pH]water (1.0 /-LCi), and [113mIn]EDTA (10 -25 /-LCi) was rapidly injected into the common carotid artery in pentobarbital-anesthetized adult rats or rabbits, ether anesthetized newborn and suckling rabbits, or via cardiac (left ventricular) puncture in ether-anesthetized newborn rats. The animals were decapitated after injection, and the brain uptake index (BUI) was determined as previ ously described (Cornford et ai., 1978b; Braun et ai., 1980) . Adult rats were guillotined 5 s after the injection, and newborn rats after 15 s; rabbits were decapitated at either 10 s (adults) or 15 s (neonates), as described previously (Braun et ai., 1980) . In this intra-arterial bolus injection method, the tritiated water serves as a diffusible refer ence, a 14C drug represents the test substance, and the [ll3mIn]EDTA chelate provides an estimate of the distri bution space of the cerebral vasculature. The mixture of isotopes injected was routinely buffered with 10 mM HEPES (Calbiochem, La Jolla, CA, U.S.A.). Radioiso topes and chemicals typically made up 20-25% of the total volume of the mixture injected, and the remaining 75-80% volume was occupied either by Ringers saline or serum. The brain was removed, and the hemisphere ip silateral to the carotid injection was sampled and pre pared for simultaneous 3H, 14C, and 113mln counting.
In studies of 28-day-old rabbits, a 0.2-ml volume was injected. In adult (�2 kg) rabbits, the method differed in that the anesthetic, sodium pentobarbital (Diabutal®, -40 mglkg; Diamond Laboratories), was administered i.v., and a larger needle (22 gauge) and injection volume (1.0 m!) were used. Because of the larger brain size, quadruplicate samples from the neocortex and paleocortex of the ipsi lateral forebrain were routinely prepared for scintillation counting and analysis of brain uptake, as described pre viously (Cornford et ai., 1978a) . Brain uptake of a 14C_ labeled test substance is expressed relative to the uptake of tritiated water eHOH), and the third isotope, 113mln (chelated to EDTA), does not cross intact membranes and serves as a marker identifying that portion of the isotopes remaining in the vasculature. Subtraction of this amount provides an estimate of the amount incorporated by brain (the BUI). The ipsilateral forebrain was dissected out, and the tissue was digested with an organic base (So luene®, Packard Instruments) and routinely counted without delay in a liquid scintillation counter for indium content. Days later, after all of the 113mIn (t 1 /2 = 100 min) had decayed, the vials were recounted for tritium and 14C content.
Data analysis
The net indium counts were obtained by subtraction and appropriate decay correction. (When vials are se quentially counted for indium disintegrations in I min, each successive vial must be decay-corrected for the elapsed counting time, i.e., 1.0 min plus the time required by the machine to change samples-O.3 min.) Counts per minute (cpm) recorded on the liquid scintillation counter were converted to disintegrations per minute (dpm) by cubic regression analysis on a Hewlett-Packard 9820 pro grammable calculator.
BUIs were determined as defined by Oldendorf and Braun (1976) in which mix is the isotope mixture injected into the ca rotid artery. The indium-EDTA uptake index (lUI) is de fined as the subtrahend of the BUI ratio described above. The single-pass extractions (E%) were derived from the measured BUI of butanol .
The BUI is defined as ED/EHOH, where ED is the extrac tion of 14C drug, and EHOH is the extraction of the [3H]water internal reference. The BUI is a direct measure of ED, since EHOH does not change appreciably in the newborn, suckling, or adult animal (Cornford et aI., 1982a) . E% may be normalized for flow differences through the use
is the cerebral blood flow rate and PS is the BBB per meability surface product for the drug (Crone, 1963) . The proportion of protein-bound and freely dialyzable drug was determined by equilibrium dialysis against a 10fold greater volume of Ringers saline (10 mM HEPES buffer, pH 7.55, with 0.05% sodium azide) in vitro, as described elsewhere (Cornford et ai., 1979) . The propor tion of exchangeable drug in vivo is determined from the ratio [B UIseru m ]/[BUIsaline] (Pardridge, 1981) . Unless otherwise indicated, all values are presented in the form of a mean (X), standard deviation (SD), and sample number (n). Student's t test was employed as an indicator of statistical significance.
Radiochemicals
The radiochemicals 5,5-[ 4-14C]diphenylhydantoin (phe nytoin, 40-60 mCi/mmol); 5[ring-2-14C]ethyl-5-phenyl barbituric acid (phenobarbital, 40-60 mCi/mmol), [1methyi-14C]caffeine (50 mCi/mmol), and tritiated water (l mCi/g) were purchased from New England Nuclear (Boston, MA, U.S.A.), and were of the highest specific activity available. Defatted bovine serum albumin (Sigma Chemical Co., St. Louis, MO, U.S.A.) was added at a concentration of 0.1 % to effect solubility of the drug in instances when the drug concentration exceeded the quantity of drug from the radioisotope alone (i.e., in testing for saturable uptake).
[14C]Diacetyl morphine was pre pared by Rosechem Radioactive Products (Los Angeles, CA, U.S.A.). The I13mIn generator was supplied by New England Nuclear radiopharmaceutical division (North Bilerica, MA, U.S.A.). The radioisotopic purity of each 14C test isotope was routinely confirmed after thin-layer chromatography (TLC) separation on silica gel plates with a solvent system recommended by the manufacturer. Dried plates were scanned with a Berthold Varian radiochro matogram scanner.
RESULTS
Brain extraction of anticonvulsant drugs and cerebral blood flow
As indicated in Ta ble I, brain extraction of the two anticonvulsants phenytoin and phenobarbital was two-to three-fold greater in newborn than in adult rats. Since increased brain extraction of drugs in the newborn may be caused by either increased BBB permeability or by decreased blood flow, we examined age-related changes in extraction and flow in developing rabbits. Owing to the larger size of newborn rabbits, quantitative measurements of ce rebral blood flow could be obtained. As in the new born rat (Table 1) , elevated brain extraction of an ticonvulsant drugs is observed in the newborn rabbit, and this phenomenon persists through 14 days post partum ( Fig. 1 ). By 21 days of age, brain extractions decrease and show an inverse relationship to age. 
Age-dependent alteration in BBB transport of the an ticonvulsants phenytoin (5,5-diphenylhydantoin) and pheno barbital, compared to that of heroin and caffeine. Significant [p < 0.05, Dunnett's (1964) modified ttest] reductions in brain extraction of these two anticonvulsants occurred in the pe riod 14-28 days after birth. The brain extractions depicted are means; vertical bars (phenytoin and phenobarbital) rep resent 1 SO; the coefficients of variation for heroin and caf feine never exceeded 12%; n = 3-8.
In contrast, age-dependent alteration in brain ex traction of the highly lipophilic drugs caffeine and heroin (diacetyl morphine), two compounds known to affect the central nervous system, were not ob served (Fig. 1) . When brain extractions of anticonvulsants were corrected for age-related alterations in cerebral blood flow, resulting values for PS of phenobarbital and phenytoin show no age-dependent diff erences. Given F = 0.25 and 0.88 ml min -I g-I for the ether-anes thetized newborn and 28-day-old rabbit, respec tively (Pardridge and Mietus, 1980; Pardridge, un published observations), then PS = -F In[1 -E] = 0.16 and 0.13 ml min -1 g -1 for phenobarbital in the newborn and 28-day-old rabbit, respectively of adult rats) was tested at a concentration of 75%. b Unidirectional clearance = (BUI) (EHOH) (F), in which EHOH is assumed to be 0.85 for both adult and neonate, and cerebral blood flow (F) = 0.6 ml min -I g-I in the barbiturate-anesthetized adult rat (Cornford et a!., 1982a) , and 0.28 ml min-I g-I in the ether-anesthetized newborn (Pardridge and Mietus, 1980) .
Values are means ± SD (n = 3-6).
(these values are not significantly different). Simi larly, for phenytoin, PS = 0.22 and 0.2 1 ml min-1 g-l in the newborn and 28-day-old rabbit. The ED values were obtained from the data in Fig. 1 and from EHOH for the newborn and 28-day-old rabbit (Cornford et aI., 1982a) . Age-related changes in PS for heroin and caffeine cannot be calculated with certainty, owing to the near-maximal extraction for these compounds (Fig. 1 ) and the logarithmic rela tionship between extraction, flow, and PS. Thus, the increase in brain extraction of anticonvulsants in the newborn can be attributed to a reduced ce rebral blood flow rate in the neonate. Recent studies (Cremer et aI., 1976; Braun et aI., 1980; Cornford et aI., 1982a) suggest BBB transport mechanisms may operate at much higher rates in the newborn than in the adult brain. Consequently, we sought to preclude the possibility that elevated brain uptake of phenytoin in the newborn might be due to the induction of a saturable, carrier-mediated transport system. In the newborn rabbit, brain ex traction of phenytoin at a trace «0.0 1 j-lg/ml) con centration (E = 58 ± 6%) was not different from the brain extraction when the phenytoin concentra tion was 20 j-lg/ml (E = 56 ± 9%) or 100 j-lg/ml (E = 55 ± 4%). At a trace concentration in 70% nor mal rat serum, Ephenytoin = 60 ± 8%, and at a con centration of 500 j-lg/ml in 70% normal rat serum, Ephenytoin = 60 ± 7%. Thus, the elevated brain ex traction of phenytoin could not be attributed to a specific carrier-mediated transport mechanism in the neonatal brain.
Role of plasma protein binding of anticonvulsants in the newborn
The decreased cerebral blood flow rate in the newborn would be expected to prolong capillary transit time, since these two parameters are gen erally inversely related (Goresky and Rose, 1977) . Moreover, these anticonvulsants are bound to plasma proteins, and the transport of protein-bound drugs into brain is enhanced by increases in capil lary transit time (Pardridge, 198 1) . Therefore, we investigated the possibility that the exchangeable fraction of circulating drug may be increased in the newborn. As shown in Ta ble 1, when the injected solution contained 75% fetal cord serum, no alter ation in neonatal brain uptake of either phenytoin or phenobarbital was observed. In contrast, the in clusion of 75% (adult human) serum in studies of adult rats results in a much reduced transport of both phenobarbital and phenytoin, relative to that seen in the presence of saline.
Similar observations were also made for the new born rabbit. Brain extraction of phenytoin in saline (E = 59 ± 5%) was similar to that measured in the presence of 75% fetal (E = 56 ± 6%) or adult (E = 50 ± 3%) human serum. Thus, like the rat (Table  1) , the newborn rabbit brain was able to maximally extract free and protein-bound phenytoin, and brain uptake was not altered by increased plasma drug levels.
The brain extraction measured in saline provides an estimate of maximal blood-to-brain transfer, and uptake measured in the presence of serum is rep resentative of the in vivo situation, wherein a con siderable fraction of the drug may be bound to plasma proteins. Comparison of brain uptake in serum divided by the uptake in saline provides the fraction of the total exchangeable drug transferred from blood to brain in a single capillary passage. As indicated in Fig. 2, 100% of the exchangeable phenobarbital gains access to the neonatal brain, in comparison to <50% in the adult. The similarity in exchangeable phenobarbital (in the adult rat brain in vivo) and the percentage of free drug in vitro (i.e., the dialyzable fraction) indicates that in the adult Approximately 60% of the phenobarbital was freely dialyz able from adult sera, and a similar quantity (59.4%) was ex changeable, suggesting that in vivo lipid-mediated transport of this drug was restricted to the free phenobarbital, and no protein-bound drug was transported. In contrast, in the ne onate, all of the exchangeable phenobarbital may penetrate the BBB, even though only 72% of the drug was freely di alyzable. Thus, transport of protein-bound phenobarbital oc curs in the newborn brain. Blank columns, % exchangeable (brain capillary, in vivo); striped columns, % unbound (equi librium dialysis, in vitro).
BBB, there is little or no transport of phenobarbital, which enters the capillary bound to protein.
The similarities in neonatal brain phenytoin up take in the presence or absence of serum suggests that >95% of the total serum drug gains access to the newborn brain. In the adult brain, �45% of the (total) exchangeable phenytoin traverses the BBB. Since the free (dialyzable) fraction represents only 13% (adult) to 15% (neonate) of the total drug, a considerable portion of the drug, which enters the capillary bound to protein, is extracted during a single transit through the brain vasculature.
DISCUSSION
For more than a decade, there have been discus sions as to whether the clinical determination of anticonvulsant serum levels should focus on free, rather than total (free + bound) drug (Reidenberg et aI., 1971; Lund et aI., 1972; Bochner etal., 1974) . Our data suggest that total serum levels may be particularly appropriate in neonates, since it is in dicated that protein-bound anticonvulsant is avail able for equilibration to the brain during a single capillary transit. A possible consequence of the in creased availability of protein-bound drug in the ne onate is the increased potential for intoxication in newborns. It has also recently been demonstrated that other anticonvulsant drug treatments delay brain maturation in laboratory animals (Thurston et aI., 1981) , and the incidence of birth defects associated with phenytoin and phenobarbital treatments (Segal, 1979; Mallow et aI., 1980) further emphasizes the sensitivity of developing tissues to these drugs.
The age-related differences in brain extraction of phenytoin and phenobarbital are defined here, and it is shown that brain extraction of anticonvulsants is increased in the newborn. When the extraction data were corrected for age-related differences in cerebral blood flow (i.e., determination of clearance = E . F, or permeability x surface area product = PS = -F' In[1 -E]), it was apparent that the higher brain extraction of anticonvulsants in the newborn is indeed a function of reduced cerebral blood flow rate in the neonate. Comparisons of P S products (see Results) demonstrated that BBB per meability is not increased in neonates (as compared to adults), confirming previous reports (Cornford et aI., 1982b) . Defining the role of cerebral blood flow rate in the present study is also important, because the different methods of anesthesia (ether in new borns, pentobarbital in adults) are known to have opposite effects on blood flow (McDowall, 1965) .
When brain uptakes were measured with serum present in the injection medium, the fraction of ex-J Cereb Blood Flow Metabol, Vol. 3, No.3, /983 changeable drug in serum could be derived (see Methods). The similarity in exchangeable pheno barbital (in the rat brain in vivo) and the percentage of freely dialyzable drug in vitro (Fig. 2) indicated that there is no transport of protein-bound pheno barbital in the adult brain. In contrast, protein-bound phenobarbital did gain access to the newborn brain in a single transcapillary passage (Fig. 2 ). Protein bound phenytoin is able to traverse capillary endo thelia in both the newborn and adult brain (Fig. 2) .
These results are consistent with the' 'free inter mediate" model for the capillary transport of pro tein-bound substances (Pard ridge , 1981; Pardridge et aI., 1983) . Presumably, the capillary transit time is shorter in the adult because of the increased blood flow rate. If the rate of unidirectional dissociation of anticonvulsant from serum protein is such that little or no bound drug dissociates in a single trans capillary passage, then brain clearance will be a function of the concentration of unbound drug. However, if the capillary transit time is slow rela tive to the rate of drug dissociation from serum pro tein, then clearance will be a function of the total (both free and bound) drug in the plasma. We as sume that the rate of dissociation for phenytoin is intermediate between the longer capillary transit time in the newborn and the shorter transit time in the adult brain. Also, the dissociation rate for pheno barbital is assumed to be slightly greater than the newborn transit time. Thus, in the newborn brain, the transit time is sufficient for both anticonvulsant drugs to dissociate and penetrate the capillary mem brane. However, in the adult brain, dissociation of phenobarbital does not occur within a single capil lary transit, and hence no transport of the protein bound drug occurs. Some dissociation of protein bound phenytoin during this same transit time would explain why some transport of protein-bound phe nytoin is observed in the adult.
Aside from differences in capillary transit time, a developmental decrease in cerebral blood flow rate may also be the result of decreased capillary density in younger animals. With respect to the present studies, it should be noted that whereas morpho metric studies clearly demonstrate increasing cap illary densities in suckling, weanling, and adult rat brains, similar capillary densities characterized the newborn, suckling, and senescent age groups (Bums et aI., 1981) . In addition, decreased capillary den sity would also result in a diminished capillary sur face area, and we observed no developmental changes in the PS product for these two anticon vulsants. Loss of cerebral endothelia, observed in older rats, is thought to be compensated for in part by cellular elongation (Bar, 1978) , an explanation that would assume minimal changes in surface areas and would be consistent with our results.
The unbound fraction of a drug is generally con sidered to be therapeutically active, presumably be cause protein-bound drug has limited access to pharmacological receptor sites (Rane et aI., 1971) . The present studies emphasize that the fraction of drug that is freely dialyzable in vitro is not always equal to the fraction gaining access to the target site in a single capillary transit. Furthermore, when drug protein dissociation rates are rapid compared to the capillary transit time, the protein-bound drug may readily gain extravascular distribution, without con comitant migration of plasma proteins across the capillary wall. Thus, variations in capillary transit times, and their relationship to dissociation rates of protein-bound drugs, appear to be important in un derstanding the role cerebral blood flow rates play in anticonvulsant delivery to brain.
Since cerebral blood flow rates are increased in seizure states, and since phenytoin is often used in the acute treatment of major motor status epilep ticus, it is interesting to note that the present data indicate that delivery of bound phenytoin (to the brain of experimental animals) is reduced in re sponse to elevations in blood flow. Developing ad junct treatments to achieve maximal drug delivery to brain would increase the efficacy of phenytoin in this clinical situation. Tr ansient alterations in blood flow and promoting the release of protein-bound drug are two mechanisms that might be worthy of additional study.
Finally, it should be emphasized that the present studies provide measurements of unidirectional clearance by brain of phenytoin and phenobarbital. Unidirectional clearance measurements, which iso late the effects of plasma proteins on capillary transport, should be distinguished from net meta bolic drug clearance. The latter is a function of tissue binding and enzymatic degradation, as well as plasma protein-binding of the drug. Changes in the unidirectional and net clearance estimates would be expected to be parallel when net metabolic clear ance is largely a function of drug availability to tis sues, since drug availability is a function of the uni directional clearance of drug by the tissue. In this regard, the present studies indicate phenytoin uni directional clearance is increased in the newborn, whereas others suggest net metabolic clearance of this drug is reduced in the neonate (Mirkin, 1971; Painter et al., 1981) . Thus, it is likely that the net clearance of phenytoin in the newborn is limited not by drug availability, but rather by intracellular en zymatic capacity.
